|
[Related PubMed/MEDLINE] Total Number of Papers: 290
|
|
|
[Display Entries]
|
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of
|
|
|
|
Abbreviation |
: 3-AB |
Long Form |
: 3-aminobenzamide |
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2022 |
Sevoflurane exposure during the second trimester induces neurotoxicity in offspring rats by hyperactivation of PARP-1. |
AIF, DHE, MWM, Nogo-A, PARP-1, PND 28-33, Pyk2, ROS, STEP61 |
2 |
2020 |
3-Aminobenzamide alleviates elevated DNA damage and DNA methylation in a BTBR T+Itpr3tf/J mouse model of autism by enhancing repair gene expression. |
--- |
3 |
2020 |
Effect of 3-Aminobenzamide on the Ultrastructure of Astrocytes and Microvessels After Focal Cerebral Ischemia in Rats. |
BBB, EB, i.p, PARP |
4 |
2020 |
Effects of the DNA repair inhibitors, cytosine arabinoside and 3-aminobenzamide, on the frequency of radiation-induced micronuclei, nuclear buds, and nucleoplasmic bridges. |
CBMN, MN, NBUD, NPB |
5 |
2020 |
Function and mechanism of combined PARP-1 and BRCA genes in regulating the radiosensitivity of breast cancer cells. |
CTRL, IR, PARP-1 |
6 |
2020 |
mTOR may interact with PARP-1 to regulate visible light-induced parthanatos in photoreceptors. |
AIF, ERG, mTOR, PI, shRNA, SIRT1 |
7 |
2020 |
Synthesis, chemical characterization, PARP inhibition, DNA binding and cellular uptake of novel ruthenium(II)-arene complexes bearing benzamide derivatives in human breast cancer cells. |
PARP-1 |
8 |
2019 |
3-Aminobenzamide Blocks MAMP-Induced Callose Deposition Independently of Its Poly(ADPribosyl)ation Inhibiting Activity. |
MAMPs, PARPs, PMR4 |
9 |
2019 |
3-Aminobenzamide protects against cerebral artery injury and inflammation in rats with intracranial aneurysms. |
HE, IA, SD |
10 |
2019 |
Chrysophanol protects against doxorubicin-induced cardiotoxicity by suppressing cellular PARylation. |
CHR, DOX |
11 |
2019 |
Combined Administration of Poly-ADP-Ribose Polymerase-1 and Caspase-3 Inhibitors Alleviates Neuronal Apoptosis After Spinal Cord Injury in Rats. |
AIF, PARP-1, SCI |
12 |
2019 |
Potential role of poly (ADP-ribose) polymerase in delayed cerebral vasospasm following subarachnoid hemorrhage in rats. |
CRP, DCVS, MCP-1, NF, SAH |
13 |
2019 |
Screening of the chemoprotective effect of 13 compounds and their mixtures with sodium 2-mercaptoethanesulfonate against 2-chloroethyl ethyl sulfide. |
CEES, MESNA, NAC |
14 |
2019 |
Treatment with 3-aminobenzamide during ex vivo lung perfusion of damaged rat lungs reduces graft injury and dysfunction after transplantation. |
BAL, CI, CTRL, EVLP, PARP, WI |
15 |
2018 |
3-Aminobenzamide Prevents Concanavalin A-Induced Acute Hepatitis by an Anti-inflammatory and Anti-oxidative Mechanism. |
DPI, LPS, NAC, PARP-1 |
16 |
2018 |
Modulation of hypersensitivity to oxidative DNA damage in ATM defective cells induced by potassium bromate by inhibition of the Poly (ADP-ribose) polymerase (PARP). |
ATM, LCLs |
17 |
2017 |
A transcriptomics approach uncovers novel roles for poly(ADP-ribosyl)ation in the basal defense response in Arabidopsis thaliana. |
3-MB, MAMPs, PARP |
18 |
2017 |
Anti-apoptotic effect of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) polymerase, against multiple organ damage induced by gamma irradiation in rats. |
ATP, COX-2, Gy, IR, LDH, MPO, TBARS |
19 |
2017 |
Inhibitors of telomerase and poly(ADP-ribose) polymerases synergize to limit the lifespan of pancreatic cancer cells. |
--- |
20 |
2017 |
Poly(ADP-ribose) polymerase 1 induces cardiac fibrosis by mediating mammalian target of rapamycin activity. |
AAC, CFs, mTOR, NAD, PARP-1 |
21 |
2017 |
Simultaneous blockade of NMDA receptors and PARP-1 activity synergistically alleviate immunoexcitotoxicity and bioenergetics in 3-nitropropionic acid intoxicated mice: Evidences from memantine and 3-aminobenzamide interventions. |
3-NP, COM, HD, MN, SDH |
22 |
2016 |
3-aminobenzamide, one of poly(ADP-ribose)polymerase-1 inhibitors, rescuesapoptosisin rat models of spinal cord injury. |
AIF, Bcl-2, CNS, PARP-1, SCI, SD |
23 |
2016 |
Mechanisms underlying lung resistance-related protein (LRP)-mediated doxorubicin resistance of non-small cell lung cancer cells. |
DOX, LRP, MVP, NSCLC, siLRP |
24 |
2016 |
PARP inhibition attenuates neuroinflammation and oxidative stress in chronic constriction injury induced peripheral neuropathy. |
CCI, COX-2, ISO, NF-kappaB, SFI |
25 |
2016 |
Pharmacological Reconditioning of Marginal Donor Rat Lungs Using Inhibitors of Peroxynitrite and Poly (ADP-ribose) Polymerase During Ex Vivo Lung Perfusion. |
EVLP, PARP, ROS, WI |
26 |
2016 |
Poly(ADP-ribose) polymerase regulates glycolytic activity in kidney proximal tubule epithelial cells. |
PARP |
27 |
2016 |
Poly(ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors Reduce Reactive Gliosis and Improve Angiostatin Levels in Retina of Diabetic Rats. |
DR, GFAP, NAM, PARP-1, PARs, STZ |
28 |
2016 |
The effect of poly (ADP-ribose) polymerase inhibition on aminoglycoside-induced acute tubular necrosis in rats. |
AG, PARP, PCNA, ROS, TIA |
29 |
2016 |
The poly(ADP-ribosyl)ation of FoxO3 mediated by PARP1 participates in isoproterenol-induced cardiac hypertrophy. |
Ad-PARP1, FoxO3, ISO, PAR, PARP-1, PARylation, SD |
30 |
2015 |
3-aminobenzamide, a poly (ADP ribose) polymerase inhibitor, enhances wound healing in whole body gamma irradiated model. |
ACOX-2, ROS |
31 |
2015 |
Effect of 3-aminobenzamide on perforation an experimental colitis model. |
MDA, TNF-alpha |
32 |
2015 |
Inhibition of Poly-(ADP-Ribose) Polymerase Protects the Kidney in a Canine Model of Endotoxic Shock. |
AKI, ES, PARPs |
33 |
2015 |
PARP inhibition prevents acetaminophen-induced liver injury and increases survival rate in rats. |
PARP |
34 |
2014 |
3-Aminobenzamide--a PARP inhibitor enhances the sensitivity of peripheral blood micronucleus and comet assays in mice. |
PARP, PBMN |
35 |
2014 |
A new combination therapy in severe acute pancreatitis--hyperbaric oxygen plus 3-aminobenzamide: an experimental study. |
AP, Bact-Trans, HBO, THSc, TOSp |
36 |
2014 |
Attenuation of the progression of adjuvant-induced arthritis by 3-aminobenzamide treatment. |
AIA, i.p, PARP, RA |
37 |
2014 |
Effects of 3-aminobenzamide on ventricular function in infarct heart assessed by quantitative tissue velocity imaging. |
MI, PARP |
38 |
2014 |
Efficacy of poly(adenosine diphosphate-ribose) polymerase inhibition in extracorporeal shock wave-induced renal injury. |
ESW, PARP |
39 |
2014 |
Ex vivo protective effects of nicotinamide and 3-aminobenzamide on rat synaptosomes treated with Abeta(1-42). |
AD, NA, PARP-1 |
40 |
2014 |
Necroptosis and parthanatos are involved in remote lung injury after receiving ischemic renal allografts in rats. |
Nec-1, Rip1 |
41 |
2014 |
Poly(ADP-ribose) polymerase activation mediates synchrotron radiation X-ray-induced damage of rodent testes by exacerbating DNA damage and apoptotic changes. |
DSB, NAC, PAR, PARP, SR, TUNEL |
42 |
2014 |
Protective effect of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) polymerase in distant liver injury induced by renal ischemia-reperfusion in rats. |
IR, MDA, NO, OSI, TAS, TOS |
43 |
2014 |
Salvianolic acid B protects cardiomyocytes from angiotensin II-induced hypertrophy via inhibition of PARP-1. |
Ang II, Sal B |
44 |
2013 |
Continuous inhibition of poly(ADP-ribose) polymerase does not reduce reperfusion injury in isolated rat heart. |
PARP |
45 |
2013 |
Docosahexaenoic acid and tetracyclines as promising neuroprotective compounds with poly(ADP-ribose) polymerase inhibitory activities for oxidative/genotoxic stress treatment. |
AIF, DHA, MNNG, PAR, PARP-1 |
46 |
2013 |
Effects of poly (ADP-ribosyl) polymerase (PARP) inhibitor on cisplatin resistance & proliferation of the ovarian cancer C13* cells. |
Pt, RT-PCR |
47 |
2013 |
Expression and activity of PARP family members in the hippocampus during systemic inflammation: their role in the regulation of prooxidative genes. |
COX-2, iNOS, LPS, PAR, PARP-1, SIR |
48 |
2013 |
Inhibition of poly (adenosine diphosphate-ribose) polymerase attenuates lung-kidney crosstalk induced by intratracheal lipopolysaccharide instillation in rats. |
ARDS, IL, LPS, NF, PARP, TNF |
49 |
2013 |
Involvement of homologous recombination in the synergism between cisplatin and poly (ADP-ribose) polymerase inhibition. |
5-FU, ESCC |
50 |
2013 |
Poly(ADP-ribose) polymerase-1 regulates the mechanism of irradiation-induced CNE-2 human nasopharyngeal carcinoma cell autophagy and inhibition of autophagy contributes to the radiation sensitization of CNE-2 cells. |
IR, LC3, PAR, PARP-1, RAPA, TEM |
51 |
2012 |
3-Aminobenzamide protects primary human keratinocytes from UV-induced cell death by a poly(ADP-ribosyl)ation independent mechanism. |
PARylation |
52 |
2012 |
NGF promotes long-term memory formation by activating poly(ADP-ribose)polymerase-1. |
NGF |
53 |
2012 |
Poly(ADP-ribosylation) and neoplastic transformation: effect of PARP inhibitors. |
PARPs |
54 |
2012 |
Suppressive effect of PARP-1 inhibitor on JC virus replication in vitro. |
JCV, PML |
55 |
2011 |
Novel pathway of centrosome amplification that does not require DNA lesions. |
MNNG, PARPs |
56 |
2011 |
PARP inhibition restores erectile function by suppressing corporal smooth muscle apoptosis in diabetic rats. |
AIF, ATP, Bad, Bax, Bcl-2, ED, i.p, MDA, PARP |
57 |
2011 |
Poly(ADP-ribose) polymerase 1 is indispensable for transforming growth factor-beta Induced Smad3 activation in vascular smooth muscle cell. |
PARP-1, ROS, SBE, TGF-beta, VSMCs |
58 |
2011 |
The poly(ADP-ribose) polymerase-1 inhibitor 3-aminobenzamide suppresses cell growth and migration, enhancing suppressive effects of cisplatin in osteosarcoma cells. |
PARP |
59 |
2011 |
[Suppressing poly(ADP-ribose)polymerase-1 inhibits tau phosphorylation in HEK293/tau441 cells]. |
GSK-3, PARP-1 |
60 |
2010 |
Effect of acute poly(ADP-ribose) polymerase inhibition by 3-AB on blood-brain barrier permeability and edema formation after focal traumatic brain injury in rats. |
BBB, MMP-9, MRI, PARP, TBI |
61 |
2010 |
Effects of 3-aminobenzamide on unilateral testicular ischemia-reperfusion injury: what is the role of PARP inhibition? |
CAT, GSH-Px, I/R, SOD |
62 |
2010 |
Fertilization capacity with rainbow trout DNA-damaged sperm and embryo developmental success. |
--- |
63 |
2009 |
3-aminobenzamide, a poly ADP ribose polymerase inhibitor, attenuates renal ischemia/reperfusion injury. |
AST, BUN, I/R |
64 |
2009 |
Identification and expansion of human osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide treatment. |
--- |
65 |
2008 |
Combinatorial-approached neuroprotection using pan-caspase inhibitor and poly (ADP-ribose) polymerase (PARP) inhibitor following experimental stroke in rats; is there additional benefit? |
MCAO |
66 |
2008 |
Effect of 3-amino benzamide, a poly(adenosine diphosphate-ribose) polymerase inhibitor, in experimental caustic esophageal burn. |
GPx, MDA, PCC, SOD |
67 |
2008 |
GSK-3beta and oxidative stress in aged brain. Role of poly(ADP- -ribose) polymerase-1. |
GSK-3 |
68 |
2008 |
Induction of cytogenetic adaptive response in spermatogonia and spermatocytes by pre-exposure of mouse testis to low-dose (12)C(6+) ions. |
PARPs |
69 |
2008 |
Ischemic and peroxynitrite preconditioning effects in chronic hypoxic rat lung. |
NO |
70 |
2008 |
Meta-iodobenzylguanidine, an inhibitor of arginine-dependent mono(ADP-ribosyl)ation, prevents neointimal hyperplasia. |
MIBG, PARP |
71 |
2008 |
Non-enzymatic fast repair of DNA oxidative damage might also exist in cells. |
CHO, MMP, MX, NIC, RA, ROS, VER |
72 |
2008 |
Poly (ADP-ribose) polymerase inhibition improves endothelial dysfunction induced by hyperhomocysteinemia in rats. |
ET, Hhcy |
73 |
2008 |
[Effect of poly-adenosine diphosphate ribosyl-polymerase on vascular hyporeactivity in rats with hemorrhagic shock]. |
NE, NO, PARP, SD, SMA |
74 |
2007 |
Inhibition of poly(ADP-ribose) polymerase (PARP) influences the mode of sulfur mustard (SM)-induced cell death in HaCaT cells. |
PARP, SM |
75 |
2007 |
Lactate down-regulates cellular poly(ADP-ribose) formation in cultured human skin fibroblasts. |
NHDF, pADPR, PARP-1 |
76 |
2007 |
Oxidative stress-induced poly(ADP-ribosyl)ation in chick limb bud-derived chondrocytes. |
HDC, PARP-1 |
77 |
2007 |
Poly(ADP-ribose) polymerase inhibitor is neuroprotective in epileptic rat via apoptosis-inducing factor and Akt signaling. |
PARP |
78 |
2006 |
Effect of 3-aminobenzamide on Bcl-2, Bax and AIF localization in hippocampal neurons altered by ischemia-reperfusion injury. the immunocytochemical study. |
AIF |
79 |
2006 |
Effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) polymerase, in a mouse model of acute pancreatitis induced by cerulein. |
ICAM-1, TGF-beta, VEGF |
80 |
2006 |
Effects of poly(ADP-ribose) polymerase inhibition on dysfunction of non-adrenergic non-cholinergic neurotransmission in gastric fundus in diabetic rats. |
eNOS, NO, PARP |
81 |
2006 |
In vivo exposure of swiss albino mice to chronic low dose of dimethylnitrosamine (DMN) lowers poly-ADP-ribosylation (PAR) of bone marrow cell and blood lymphocyte proteins. |
BL, BMC, DMN, PAR |
82 |
2006 |
Inhibition of poly(ADP-ribose)polymerase does not affect the recombination events in CHO xrs6 and wild type cells. |
HR, NHEJ |
83 |
2006 |
Poly (ADP-ribose) polymerase inhibitor 3-aminobenzamide rescues N-methyl-N-nitrosourea-induced photoreceptor cell apoptosis in Sprague-Dawley rats through preservation of nuclear factor-kappaB activity. |
MNU, NF |
84 |
2006 |
Poly(ADP-ribose) polymerase-1 inhibitor 3-aminobenzamide enhances apoptosis induction by platinum complexes in cisplatin-resistant tumor cells. |
--- |
85 |
2005 |
3-aminobenzamide prevents restraint-evoked immunocompromise. |
KLH, PARP |
86 |
2005 |
Effect of 3-aminobenzamide, PARP inhibitor, on matrix metalloproteinase-9 level in plasma and brain of ischemic stroke model. |
MMP-9, NF-kappaB, PARP |
87 |
2005 |
Effect of poly(ADP-ribosyl)ation inhibitors on the genotoxic effects of the boron neutron capture reaction. |
5-AIQ, BNC, DNA-PK, PARP-1 |
88 |
2005 |
Inhibition of poly(ADP-ribose) polymerase activity protects hippocampal cells against morphological and ultrastructural alteration evoked by ischemia-reperfusion injury. |
GFAP |
89 |
2005 |
Inhibition of poly(ADP-ribose) polymerase attenuates lung tissue damage after hind limb ischemia-reperfusion in rats. |
BAL, I/R, MDA, PARP |
90 |
2005 |
Inhibitors of poly (ADP-ribose) polymerase ameliorate myocardial reperfusion injury by modulation of activator protein-1 and neutrophil infiltration. |
AP-1, PARP-1 |
91 |
2005 |
Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and the development of bleomycin-induced lung injury. |
5-AIQ, PARP |
92 |
2005 |
Poly (adp-ribose) synthetase inhibition reduces oxidative and nitrosative organ damage after thermal injury. |
NAD |
93 |
2004 |
3-Aminobenzamide reduces brain infarction and neutrophil infiltration after transient focal cerebral ischemia in mice. |
MPO, PARP |
94 |
2004 |
5-Aminoisoquinolinone reduces colon injury by experimental colitis. |
5-AIQ, DNBS, ICAM-1, MPO |
95 |
2004 |
Apoptosis inhibition plays a greater role than necrosis inhibition in decreasing bacterial translocation in experimental intestinal transplantation. |
BT |
96 |
2004 |
Caspase inhibition switches the mode of cell death induced by cyanide by enhancing reactive oxygen species generation and PARP-1 activation. |
ROS |
97 |
2004 |
Caspase-1 and poly (ADP-ribose) polymerase inhibitors may protect against peroxynitrite-induced neurotoxicity independent of their enzyme inhibitor activity. |
DHQ |
98 |
2004 |
Effect of DNA repair inhibitor (3-aminobenzamide) on genetic stability of loach (Misgurnus fossilis) embryos derived from cryopreserved sperm. |
PARP |
99 |
2004 |
Effect of poly(ADP-ribose) polymerase inhibitors on oxidative stress evoked hydroxyl radical level and macromolecules oxidation in cell free system of rat brain cortex. |
DHIQ, DPQ, PARP-1 |
100 |
2004 |
Effects 3-aminobenzamide on ultrastructure of hippocampal CA1 layer after global ischemia in gerbils. |
--- |
|